Himax Technologies ADR (NASDAQ:HIMX) does about 1.74M shares in volume on a normal day but saw 1195669 shares change hands in the recent trading day. The company now has a market cap of 1.47B USD. Its current market price is $8.40, marking an increase of 1.08% compared to the previous close of $8.31. The 52 week high reached by this stock is $13.91 whilst the lowest price level in 52 weeks is $5.12.
The consensus objective for the share price is $8.60, suggesting that the stock has a potential upside of 2.33% over the period.
FactSet Research has provided data showing that 2 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Moderate Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 09, 2025 when Morgan Stanley initiated the stock to “Overweight” and issued a price target of $8.80. Credit Suisse upgraded the stock to “Outperform” from Neutral on August 11, 2023 at a price target of $8. Credit Suisse downgraded its price target at $7.
The current price level is 2.70%, 12.55%, and 14.77% away from its SMA20, SMA50, and SMA200 respectively, with the HIMX price moving below the 50-day SMA on current market day. Himax Technologies ADR (HIMX) stock is down -2.55% over the week and 9.23% over the past month. Its price is 4.48% year-to-date and 30.23% over the past year.
To reach the target analysts have set, the stock logically needs to grow 2.33 percent from here.
Outstanding shares total 174.90M with insiders holding 30.96% of the shares and institutional holders owning 19.75% of the company’s common stock. The company has a return on investment of 9.30% and return on equity of 9.79%. The price to earnings ratio (P/E ratio) amounts to 16.78 while the forward price to earnings ratio is 14.57. The beta has a value of 2.21. Price to book ratio is 1.61 and price to sales ratio is 1.61.
